BittencourtC,PivetVM,OliveiraCSV,CrispimS,MeiraD,RosaPS, 2014.Association of classical risk factors and coronary artery disease in type 2 diabetic patients submitted to coronary angiography,Diabetol Metab Syndr 6 46 -48
TakemuraY,WalshK,OuchiN., 2007.Adiponectin and cardiovascular inflammatory responses,Current Atherosclerosis reports 9 238 -43
PistroschF,NataliA,HanefeldM., 2011.Is hyperglycemia a cardiovascular risk factor? Diabetes Care, 34 128 -31
AnietabasiSO,ChinyereAO,AnoustaCN,EdmundRE,JohnUE,AnthonyJU, 2013.Adiponectin and cardiovascular risk factors in relation with glycemic control in type 2 diabetics,Int J Res Med Sci 1 563 -70
OliveiraCSV,GiuffridaFMA,CrispimF,Saddi-RosaP,ReisAF, 2011.ADIPOQ and adiponectin: the common ground of hyperglycemia and coronary artery disease,Arq Bras Endocrinol Metabol 55 446 -54
AdyaR,TanBK,RandevaHS, 2015.Differential effects of leptin and adiponectin in endothelial angiogenesis,J Diabetes Res 49 13 -21
LimS,QuonMJ,KohKK, 2014.Modulation of adiponectin as a potential therapeutic strategy,Atherosclerosis 233 721 -8
RobinsonK,PrinsJ,VenkateshB., 2011.Clinical review: Adiponectin biology and its role in inflammation and critical illness,Crit Care 15 221 -9
YamauchiT,IwabuM,Okada-IwabuM,KadowakT., .Adiponectin receptors: A review of their structure, function and how they work,Clin Endicrinol Metab. -
YamauchiT,KadowakiT., 2013.Adiponectin receptor as a key player in healthy longevity and obesity-related diseases,Cell Metabolism 17 185 -96
GhanbariAA,DorrR,SpitzerS,StumpfJ,BritzA,Amann-ZalanI, 2013.Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance,Diab Vasc Dis Res 10 452 -8
GelonezeB,PereiraJA,ParejaJC,LimaMM,LazarinMA,SouzaIC, 2009.Overcoming metabolic syndrome in severe obesity: Adiponectin as a marker of insulin sensitivity and HDLcholesterol improvements after gastric bypass,Arq Bras Endocrinol Metabol 53 293 -300
FriedwaldWT,LevyPI,FredricksonDS, 1972.Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative centrifuge,Clin Chem 18 449 -502
DelongDM,DelongER,WoodPD,LippetK,Rifkind BM, 1986.A comparison of methods for the estimation of plasma low and very low density lipoprotein cholesterol,J Am Med Assoc 256 2372 -77
MohanV,DeepaR,PradeepaR,SanthanakrishnanV,MohanA,VelmuruganK, 2005.Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CRUES-4), 54 476 -81
YuJG,JavorschiS,HevenerAL,KruszynskaYT,NormanRA,SinhaM, 2002.The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects,Diabetes 51 2968 -74
SchnabelR,MessowCM,LubosE,Espinola-KleinC,RupprechtHJ,BickelC, 2008.Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study,Eur Heart J 29 649 -57
SattarN,WannametheeG,SarwarN,TchernovaJ,CherryL,WallaceAM, 2006.Adiponectin and coronary heart disease: a prospective study and meta-analysis,Circulation 114 623 -29
RasulS,IihanA,ReiterMH,Baumgartner-ParzerS, 2011.Kautzky-willer A. Relations of adiponectin to levels of metabolic parameters and sexual hormones in elderly type 2 diabetic patients,Gender Medicine 8 93 -102
ZoccaliC,MallamaciF,TripepiG,BenedettoFA,CutrupiS,ParlongoS, 2002.Adiponectin, metabolic factors, and cardiovascular events among patients with end-stage renal disease,J Am Soc Nephrol 13 134 -41
SchulzeMB,ShaiI,RimmEB,LiT,RifaiN,HuBF, 2005.Adiponectin and future coronary heart disease events among men with type 2 diabetes,Diabetes 54 534 -39
AliM,OtokozawaS,AsztalosBF,WhiteCC,Demissie BanjawS,CupplesLA, .Adiponectin: an independent risk factor for coronary heart disease in men, -
PischonT,HuFB,GirmanCJ,RifaiN,MansonJE,RexrodeKM, 2011.Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women,Atherosclerosis 219 322 -29
ObataY,YamadaY,KyoM,TakahiY,SaishoK,TambaS, 2013.Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes,J Diabetes Invest 4 475 -82
KarastergiouK,Mohamed-AliV,JehangiriM,KaskiJ, 2009.Adiponectin for prediction of cardiovascular risk?,Br J Diabe Vascu Dis 9 150 -54
AliMK,NarayanKMV,TandonN.,Diabetes, 2010.& coronary heart disease: Current perspectives,Indian J Med Res 132 584 -97
NayakSB,MaharajN, 2012.Association between altered lipid profile, body mass index, low plasma adiponectin and varied blood pressure in Trinidad type 2 diabetic and non-diabetic subjects,J Med Sci 65 214 -21
YamamotoS,MatsushitaY,NakagawaT,HayashiT,NodaM,MizoueT., 2014.Circulating adiponectin levels and risk of type 2 diabetes in the Japanese,Nutr Diabetes 4 130 -35
TabakAG,BrunnerEJ,MillerMA,KaranamS,McTernanPG,CappuccinoFP, 2009.Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids and inflammation-Whitehall II study,Horm Met Res 41 626 -29
MatsushitaY,NakagawaT,YamamotaS,KatoT,OuchiT, 2014.Adiponectin and visceral fat associate with cardiovascular risk factors,Obesity 21 287 -91
LuoM,Oza-FrankR,NarayanKMV,GokulakrishnanK,MohanV, 2010.Serum total adiponectin is associated with impaired glucose tolerance in Asian Indian females but not in males,J Diab Sci Tech 4 645 -50
IzadiV,FarabadE,AzadbakhtL, 2013.Epidemiological evidence on serum adiponectin level and lipid profile,Int Prev Med 4 133 -40
WingRR,ReboussinD,LewisCE, 2013.Intensive lifestyle intervention in type 2 diabetes,N Engl J Med 369 145 -54
BorgesMC,LawlorDA,OliveiraCD,WhiteJ,HortaBL,BarrosAJD, 2016.Role of adiponectin in coronary heart disease risk,Circ Res 119 491 -99
LawlorDA,SmithGD,EbrahimS,ThompsonC,Sattar N, 2005.Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women,J Clin Endocrinol Metab 90 5677 -83
LindsayRS,ResnickHE,ZhuJ,TunML,HowardBV,ZhangY, 2005.Adiponectin and coronary heart disease: the strong heart study,Atheroscler Thromb Vascu Biol 25 115 -16